Avai Bio, Inc.
Avai Bio, Inc. (AVAI) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001740797 · AVAI · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001740797 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Avai Bio, Inc. (OTC: AVAI) has submitted 114 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Technology sector company with CIK 0001740797, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Avai Bio, Inc.'s most comprehensive regulatory disclosure. The most recent Avai Bio, Inc. 10-K was filed on 2025-07-08 for fiscal year ending 2025. Historical AVAI 10-K annual reports are available from 2018 through 2025.
Investors researching Avai Bio, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
AVAI SEC Filings · 8 questionsAvai Bio, Inc. (AVAI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 114 filings and access original documents at no cost. Avai Bio, Inc.'s CIK is 0001740797.